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Abstract 
 
THE RELATIONSHIPS BETWEEN PERCEIVED CRITICISM AND 
PSYCHOTHERAPY OUTCOME IN A SAMPLE OF OUTPATIENT ADOLESCENTS 
 
Rachel Elizabeth Capps 
B.S. Roanoke College 
M.A. Appalachian State University 
 
Chairperson: Dr. Kurt D. Michael, Ph.D. 
 
Expressed emotion (EE), purportedly hostile, negatively critical, and emotionally over-
involved attitudes in relationships, has been consistently implicated as a predictor of 
adolescent mental health outcomes (Peris & Miklowitz, 2015). An underlying construct 
of EE, perceived criticism (PC), subjectively assesses disapproval in relationships using 
the Perceived Criticism Measure (PCM; Hooley & Teasdale, 1989) and has been 
implicated as a predictor of clinical outcomes (Hooley & Teasdale, 1989; Masland & 
Hooley, 2015; Renshaw, Chambless, & Steketee, 2001; Renshaw, Chambless, & 
Steketee, 2003). Studies using the PCM have shown higher levels of PC predict worse 
psychological outcomes in adults (Renshaw, 2008). However, studies have yet to 
examine the PCM’s ability to predict treatment outcomes in adolescents, the stability of 
PCM ratings over the course of treatment, and the relationship between PCM item 3 
assessing upset from criticism and psychotherapy outcome. The purpose of this study is 
to examine these relationships in a clinically transdiagnostic sample of adolescents. 
Results suggest that both the level of PC and the level of upset from criticism remained 
stable over the course of treatment while YOQ-30 scores decreased on average over 
 
 
v 
 
treatment. In addition, the level of PC was not significantly related to YOQ-30 scores 
over treatment. Instead, results suggest the level of upset from criticism over 
psychotherapy predicted YOQ-30 scores with higher levels of upset relating to higher 
YOQ-30 scores. These findings suggest that the PCM can help identify treatment targets 
with adolescent samples and position PC as a potentially useful construct for predicting 
psychotherapy treatment response in teens.     
Keywords: perceived criticism, PCM, expressed emotion, treatment outcome, 
adolescent  
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Abstract 
Expressed emotion (EE), purportedly hostile, negatively critical, and emotionally over-
involved attitudes in relationships, has been consistently implicated as a predictor of 
adolescent mental health outcomes (Peris & Miklowitz, 2015). An underlying construct 
of EE, perceived criticism (PC), subjectively assesses disapproval in relationships using 
the Perceived Criticism Measure (PCM; Hooley & Teasdale, 1989) and has been 
implicated as a predictor of clinical outcomes (Hooley & Teasdale, 1989; Masland & 
Hooley, 2015; Renshaw, Chambless, & Steketee, 2001; Renshaw, Chambless, & 
Steketee, 2003). Studies using the PCM have shown higher levels of PC predict worse 
psychological outcomes in adults (Renshaw, 2008). However, studies have yet to 
examine the PCM’s ability to predict treatment outcomes in adolescents, the stability of 
PCM ratings over the course of treatment, and the relationship between PCM item 3 
assessing upset from criticism and psychotherapy outcome. The purpose of this study is 
to examine these relationships in a clinically transdiagnostic sample of adolescents. 
Results suggest that both the level of PC and the level of upset from criticism remained 
stable over the course of treatment while YOQ-30 scores decreased on average over 
treatment. In addition, the level of PC was not significantly related to YOQ-30 scores 
over treatment. Instead, results suggest the level of upset from criticism over 
psychotherapy predicted YOQ-30 scores with higher levels of upset relating to higher 
YOQ-30 scores. These findings suggest that the PCM can help identify treatment targets 
with adolescent samples and position PC as a potentially useful construct for predicting  
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psychotherapy treatment response in teens.     
Keywords: perceived criticism, PCM, expressed emotion, treatment outcome, 
adolescent  
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The Relationship Between Perceived Criticism and Psychotherapy Outcome in a Sample 
of Outpatient Adolescents 
Expressed emotion (EE) is a process by which family members communicate 
hostile, critical, and emotionally over-involved attitudes towards other family members 
(Hooley, 1985, 2007). Whereas criticism reflects an objective sense of disapproval from 
another person (e.g., parent, spouse; Hooley, 1998), perceived criticism (PC) is defined as 
a subjective sense of criticism from another person (Masland & Hooley, 2015). Hostility 
reflects a general sense of dislike of a person (Hooley, 1998), and emotional over-
involvement is the exaggerated expression of over-concern and over-protectiveness 
towards another (Michelson & Bhurgra, 2012). However, because hostility has been 
found to correlate highly with criticism, researchers have suggested that evaluating 
criticism is a more feasible approach to measuring related hostile attitudes that are 
believed to occur within families (Peris & Miklowitz, 2015).  
Based on meta-analytic reviews, EE appears to be a risk factor for relapse across a 
variety of psychological disorders in the general clinical population (Hooley, 1998). In 
adolescents, EE has been cited as a key predictor for psychological and behavioral 
problems (Wedig & Nock, 2007). Numerous studies have found that high levels of 
parental EE portend a worse course for anxiety, psychotic, and mood disorders in youth 
(Peris & Miklowitz, 2015). EE has also been found to predict a poorer treatment response 
in young people with bipolar, anxiety, depressive, and eating disorders (Asarnow, 
Tompson, Woo, & Cantwell, 2001; Peris, Yadegar, Asarnow, & Piacentini, 2013; 
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Przeworski et al., 2012; Miklowitz, Biuckians, & Richards, 2006; Le Grange, Eisler, 
Dare, & Hodes, 1992).  
Perceived Criticism 
As described above, PC is the subjective sense of criticism from another person, 
often a parent, spouse, or someone with whom the person has frequent contact (Hooley & 
Teasdale, 1989). Butzlaff and Hooley (1998) suggested that empirical inquiries focus 
primarily on the criticism component of EE because criticism is usually the factor that 
explains the most variance associated with high ratings of EE. In addition, most studies 
linking EE to poor clinical outcomes have consistently found the construct of criticism to 
account for the most variance associated with such poor outcomes (Hooley, 2007). Of 
particular importance, studies that have compared measures of PC and measures of EE as 
predictors of treatment outcome have implicated measures of PC as a better predictor of 
treatment outcome than measures of EE (Chambless & Steketee, 1999; Hooley & 
Teasdale, 1989). For example, in studies examining the clinical utility of parental EE 
with adolescent psychopathology, criticism (broadly construed) has been implicated as 
the most significant predictor of symptom course for adolescent self-injurious thoughts 
and behaviors (SITB; Wedig & Nock, 2007) and adolescent global eating disorder 
psychopathology (Schmidt, Tetzlaff, & Hilbert, 2015). Such findings warrant a closer 
examination of the criticism component in relation to adolescent psychological symptom 
experience. 
Most of the studies that have examined the relationship between PC and relevant 
outcomes (e.g., treatment response, relapse) have been conducted with adults and have 
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utilized the Perceived Criticism Measure (PCM; Hooley & Teasdale, 1989). Designed to 
be more efficient for clinical practice than other methods such as the Camberwell Family 
Interviews (CFI; Leff & Vaughn, 1985) and the Five Minute Speech Sample (FMSS; 
Magaña et al., 1986), the PCM asks respondents to identify the most influential person in 
their lives and rate the level or amount of criticism perceived in that relationship on a 
scale from 1 to 10. The full version of the PCM includes four items to provide clinically 
relevant information, but the PCM score is only comprised of the second item, “How 
critical do you think _____ is of you?” However, more recent research has indicated the 
predictive validity of other items of the PCM (Miklowitz, Wisniewski, Miyahara, Otto, & 
Sachs, 2005). 
In the first study to examine the predictive validity of the PCM, Hooley and 
Teasdale (1989) found that spousal PCM scores predicted depressive symptom relapse 
over nine months in an inpatient sample of adults with depression with a large effect size 
(r = .64). Most importantly, Hooley and Teasdale found that PCM scores were most 
strongly associated with depression relapse compared to levels of EE and marital distress. 
When PC, EE, and marital distress variables were analyzed in terms of their contribution 
to relapse rates using hierarchical regression, they found that PC ratings at baseline 
entered first and alone predicted 38% of the total variance in depression outcome. Even 
when EE and levels of marital distress were entered first into the regression, PC predicted 
a significant proportion of the remaining variance (ΔR2 = 0.16, p < .05). Hooley and 
Teasdale (1989) also examined the relationship between participants’ PCM scores and 
depressive symptoms measured with the Beck Depression Inventory (BDI; Beck, Steer, 
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& Brown, 1996) before treatment and found no relationship (r = 0.02). This lack of a 
relationship suggests that PC is not a reflection of initial symptom severity in this 
particular study.  
 With a broader or arguably transdiagnostic perspective of the relationship 
between PC and treatment outcome, Renshaw, Chambless, and Steketee (2001) examined 
depressive symptoms in a clinical sample of adults with obsessive-compulsive disorder 
(OCD) or panic disorder with agoraphobia (PDA) receiving exposure therapy to treat 
anxiety symptoms. Following exposure therapy, Renshaw and colleagues (2001) found 
participants’ depressive symptoms measured with the Symptom Checklist-90-Revised 
(SCL-90-R; Derogatis, 1994) significantly decreased. However, participants with higher 
pre-treatment PCM scores experienced less depressive symptom improvement at the end 
of treatment. In this sample, PC was the best predictor of less depressive symptom 
improvement compared to all three components of EE with a medium effect size (rpart = 
0.33). 
 In one of the few studies to test the stability of PCM scores, Renshaw, Chambless, 
and Steketee (2003) examined the relationship between PC and anxiety symptom 
improvement in participants with obsessive-compulsive disorder or panic disorder with 
agoraphobia after receiving exposure therapy based on Chambless and Steketee’s (1999) 
dataset. Participants completed pre- and post-treatment PCM ratings for a relative with 
whom they lived. Using a regression analysis controlling for all three components of EE, 
Renshaw et al. (2003) found that a higher pre-treatment PCM score was the only 
significant predictor of less anxiety symptom improvement following treatment, with a 
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medium effect size (rsemipartial = 0.36). They also found that these scores were relatively 
stable from pre- to post-treatment. Measures of symptom severity before and after 
treatment did not predict PCM ratings in this analysis, supporting the aforementioned 
finding that PC is not necessarily an indicator of more severe psychological symptoms 
(Renshaw et al., 2003).  
Although the PCM score is comprised of only item two of the four-item measure, 
Miklowitz and colleagues (2005) demonstrated the utility of an additional item that 
assesses how upset the respondent becomes as a result of criticism from his or her 
identified perceived critic in predicting symptom severity in people with bipolar disorder. 
Pointing to research findings that suggest individuals with bipolar disorder are stress-
sensitive, prone to processing biases in response to negative stimuli, and prone to 
dysfunctional attitudes, Miklowitz et al. (2005) hypothesized that individuals who 
became more upset due to criticism would have higher mood symptom scores and 
evidence fewer days in recovery. Participants in this study were adults who completed the 
PCM for at least one relative with whom they had at least four hours per week of contact 
and were involved in their health care upon entry into a longitudinal study of bipolar 
disorder. Miklowitz et al. (2005) found that the amount of criticism was not related to 
mood symptoms, but the respondents who rated being more upset as a result of criticism 
had more severe depressive symptoms over the follow-up period of three, six, nine, and 
12 months. Similarly, ratings of the amount of criticism were not related to mania 
symptoms at follow-up, but the participants who reported being more upset due to 
criticism had more severe symptoms of mania at follow-up. When examining the 
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relationship between PCM ratings and number of days in recovery, no relationship was 
found between number of days well and the level of criticism perceived from the 
identified critic, the level of criticism the respondent reported directing towards the critic, 
or how upset the critic became as a result of the respondent’s criticism (i.e., all other 
PCM items). However, participants who reported being more upset due to criticism had 
fewer days of recovery at follow-up after covarying for age, sex, baseline symptoms 
variables, and the number of assessments completed. These findings support the clinical 
importance of examining how upset the respondent becomes due to criticism in 
predicting symptom severity and highlights the salience of the emotional impact of 
criticism in predicting treatment outcomes. Further, this finding that the upset item only 
predicted fewer days in recovery, when taking into account such variables as participant 
sex and baseline symptom severity to name a few, highlights another gap in the literature 
warranting further examination.  
Perceived Criticism in Adolescents 
Almost all published studies examining the relationship between PC and symptom 
severity and PC and treatment outcome have utilized adult samples. To date, little is 
known about the relationship between PC and symptom course and the relationship 
between PC and treatment outcomes in adolescents. Indeed, few studies have assessed PC 
using the PCM with adolescents. In one of the only studies examining PC in adolescents, 
von Polier et al. (2014) correlated PCM scores for adolescents with early-onset 
schizophrenia with the quality of interactions with family and peers and quality of life 
measures and found that higher ratings of PC were inversely correlated with poorer 
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family interactions, poorer peer interactions, and worse quality of life. O’Brien, 
Miklowitz, and Cannon (2015) examined maternal PC in a mixed sample of adolescents 
and adults aged 12-35 designated at clinical high risk (CHR) for psychosis when treated 
in Family-Focused Therapy (FFT-CHR) or Enhanced Care (EC) treatment. The 
researchers measured PC using a modified scale version of the PCM assessing youths’ 
and mothers’ perceptions of maternal criticism and disapproval on a composite 0-20 scale 
at baseline and 6-month reassessment. Youths’ and mothers’ ratings of perceived 
maternal criticism were significantly higher at baseline measurement than at reassessment 
for both treatment groups. Based on these findings, the researchers concluded that 
measures of PC are likely useful in predicting the course of psychotic symptoms in CHR 
youth. However, there is a need for studies to examine the standard version of the PCM 
well-documented in the literature to determine PC’s relationship with adolescent 
treatment outcomes. These results also call into question the stability of PCM scores from 
pre- to post-treatment, which contradicts findings of pre- to post-treatment stability in the 
adult literature. Further study of the stability of PC with adolescents, therefore, must 
utilize the standard version of the PCM when examining this question to allow for more 
direct comparison to results from the adult population. 
In addition, all of the studies examining the correlation between PCM scores and 
treatment outcome have been conducted with disorder-specific samples (Renshaw, 2008). 
Studies where the relationship between PCM scores and treatment outcome have been 
examined are based on samples of adults with single or discrete conditions, such as 
depression, anxiety disorders, bipolar disorder, substance use disorder, and schizophrenia 
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(Renshaw, 2008). No studies were located that examined the relationship between PC and 
treatment outcome in a transdiagnostic sample with a mixture of clinical problems and 
expected co-morbidities often observed in clinical samples.  
The aforementioned gaps in the PC literature indicate a need to expand our 
understanding of the PCM’s utility in younger samples with a mixture of 
psychopathological symptomatology. Likewise, more research is needed to evaluate the 
utility of the PCM with transdiagnostic samples of adolescents and its relationship with 
general treatment outcomes. In addition, the stability of PCM scores over the course of 
treatment must be examined to further support PC as a construct that does not merely 
indicate psychological symptom severity. Finally, although the PCM score consists of 
only one item, further studies are needed to evaluate the PCM’s upset item in predicting 
treatment outcomes. 
Although EE is a known correlate of symptom course and treatment outcomes 
across a variety of specific disorders (Hooley & Teasdale, 1989; Masland & Hooley, 
2015; Renshaw et al., 2001; Renshaw et al., 2003), there is evidence from a number of 
studies that suggested that PC is perhaps the most powerful predictor among the 
purported components of EE (Chambless & Steketee, 1999; Hooley & Teasdale, 1989). 
However, the utility of PC has been demonstrated primarily in adult studies and less work 
has been done with younger samples. Moreover, there is a paucity of research on the 
relationship between PC and adolescent psychotherapy outcome. While several studies 
have shown that pre- to post-treatment PCM ratings are generally consistent (Renshaw et 
al., 2003), the stability of PCM ratings assessed over the course of a psychotherapy trial 
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has not been examined to date. Finally, the relationship between the amount of distress 
from criticism and treatment outcome also warrants further study. Examining whether 
such a relationship exists and the nature of this relationship is necessary to further 
elucidate how PC operates to predict psychotherapy outcomes. 
Given the current state of the literature, the following three questions were 
examined in the current study. First, how stable are PCM ratings over the course of 
psychotherapy treatment? Second, what is the relationship between PCM ratings and 
psychotherapy treatment outcomes in an adolescent sample? Third, is the PCM’s upset 
item related to treatment outcomes?  
Regarding the first research question, it was hypothesized that PCM ratings would 
be fairly stable over the course of treatment (i.e., will not have a slope statistically 
different from zero), given what has been found in the published literature to date. With 
respect to the second question, while it was generally expected that psychotherapy would 
result in symptom improvement for the sample on average, it was hypothesized that 
adolescents with relatively higher baseline PCM scores would experience relatively less 
symptom improvement over the course of treatment when compared to adolescents with 
relatively lower PCM ratings. Given the lack of findings to date supporting a theoretical 
link between increased distress from criticism and poorer treatment outcomes in 
adolescent samples, the analyses regarding the relationship between scores on the PCM’s 
upset item and psychotherapy treatment outcome was exploratory in nature. 
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Method 
Participants 
 Participants were 48 high school students between the ages of 13 and 18 (M = 
15.95, SD = 1.14) who received psychotherapy at the Assessment, Support, and 
Counseling (ASC) Center at two high schools in rural Western North Carolina between 
the fall of 2016 and the fall of 2017. The majority of students in the sample were female 
(68.80%, n = 33). Students in the sample represented all high school grade levels, with 
31.30% (n = 15) of students being the in the 9th grade, 27.10% (n = 13) in the 10th grade, 
22.90% (n = 11) in the 11th grade, and 18.80% (n = 9) in the 12th grade. The sample 
participated in between 3 and 63 treatment sessions (M = 14.44, SD = 10.87) with an 
average duration of 45.69 minutes (SD = 9.34). Students were referred for ASC services 
primarily by school counselors, school administrators, and through self-referral. Students 
aged 18 years provided their own legal consent, and parents of students younger than 18 
years-old provided written legal consent. Students younger than 18 years-old also 
provided their own assent for services. To be included in this sample, students must have 
had a T-score of 60 or greater indicating clinically significant risk of distress or 
dysfunction on any of the internalizing scales of the BASC-2 or BASC-3 SRP-A, they 
must have completed two or more YOQ-30s and PCMs, and they must have attended 
three or more treatment sessions. 
Measures 
 PCM. Participants completed the Perceived Criticism Measure (PCM; Hooley & 
Teasdale, 1989; Appendix A) at the beginning of their first meeting with an ASC Center 
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clinician, every other week during treatment, and following termination of treatment. The 
PCM does not specifically instruct respondents to identify their chosen perceived critic 
before completing the measure but instructs identification of a perceived critic in each 
item. However, studies that have examined the choice of perceived critic have shown that 
PCM scores best reflect the respondent’s emotional environment and therefore have the 
greatest predictive validity when the identified perceived critic is someone the respondent 
is related to and lives with (Renshaw, 2007).  
 For the purpose of this study, respondents were first instructed to identify their 
chosen perceived critic with the critic defined as being biologically or legally connected 
to the respondent in some way and residing with the respondent. This restriction criteria 
were worded in such a way as, “Please identify the person that you are related to and live 
with who is most emotionally important to you” (Appendix B). The participant then 
completed four items assessing the extent to which he or she believes the identified 
person is critical of him or her.  Participants rate their answers on a 10-point scale with 10 
meaning “very critical” and 1 meaning “not at all.”  Items are worded in such a way as in 
item 2, “How critical do you think [IMPORTANT PERSON] is of you?”  Other items 
assess how upset the participant becomes as a result of criticism (item three), how critical 
the participant is of the identified important person (item one), and how upset the 
identified important person becomes as a result of criticism (item four). For research 
purposes, only the second item of the PCM assessing how critical the identified important 
person is of the respondent is used to comprise the PCM score. In addition, the PCM’s 
upset item (item three) was used for exploratory analyses. 
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YOQ-30. The presence of clinical and subclinical psychological symptoms was 
measured using the Youth Outcome Questionnaire-30 (YOQ-30; Burlingame et al., 
2004). Participants completed this measure before beginning treatment, a minimum of 
every two weeks during treatment, and following treatment. As part of regular ASC 
Center services, the YOQ-30 was administered throughout treatment to measure 
psychological symptoms experienced and to measure progress throughout treatment. 
Clients rated the frequency with which they have experienced certain psychological 
symptoms over the past two weeks on a scale from 0 meaning “never” to 4 meaning 
“almost always or always.” The YOQ-30 has relatively high internal consistency for 
normative samples (α = 0.92) and outpatient normative samples (α = 0.93; Burlingame et 
al., 2004).   
BASC-2. The Behavior Assessment System for Children, 2nd Edition (BASC-2; 
Reynolds & Kamphaus, 2004) Self-Report of Personality (SRP-A) form was 
administered before beginning treatment at the ASC Center as a baseline measure of 
psychological symptoms and at the end of treatment as a post-treatment measure of 
psychological symptoms. As part of regular ASC services, the BASC-2 was administered 
at baseline and post-treatment to measure the nature and severity of psychological 
symptoms and changes in symptoms from baseline to post-treatment. The SRP-A 
requires clients to respond to personality inventory questions with either a “True” or 
“False” response or with a “Never” to “Almost always” frequency rating. The SRP-A has 
a relatively high internal consistency for normative samples (α = 0.67 – 0.96) and clinical 
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normative samples (α = 0.68 – 0.96) and an adequate test-retest reliability (r = 0.63 – 
0.84).  
BASC-3. Due to updating assessment materials during the course of data 
collection, some participants were administered the Behavior Assessment System for 
Children, 3rd Edition (BASC-3; Reynolds & Kamphaus, 2015) Self-Report of Personality 
(SRP-A) form. The BASC-3 SRP-A requires clients to respond to personality inventory 
questions in the same format as the BASC-2 with a relatively high internal consistency 
for normative samples (α = 0.71 – 0.96) and clinical normative samples (α = 0.77 – 0.96). 
The SRP-A has adequate test-retest reliability (r = 0.73 – 0.91). BASC-2 or BASC-3 
SRP-A scales were used to determine which participants’ PCM ratings were included in 
analyses 
Procedure 
 Procedures in this study were reviewed and approved by Appalachian State 
University’s Institutional Review Board (IRB) prior to beginning data collection. 
Participants and their families received full informed consent and assent before taking 
part in ASC Center services and this research study. Participation in ASC treatment was 
not contingent upon participation in this research study. At the beginning of treatment, 
participants completed the PCM as a baseline measure of PC. Additionally, participants 
completed the PCM at most every two weeks during treatment and following the 
termination of treatment. Participants rated the same individual each time the PCM was 
completed. Clinicians made note of the date of any changes in living situation that 
resulted in the participant no longer living with the chosen perceived critic and in such 
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cases the clinician obtained new PCM ratings for a perceived critic with whom the 
participant currently lived. 
 Due to the transdiagnostic nature of the sample, psychotherapy treatment 
consisted primarily of non-manualized cognitive behavioral therapy (CBT) and 
occasionally non-manualized dialectical behavioral therapy (DBT) depending upon the 
nature of each student’s presenting concern. Clinicians who provided treatment consisted 
of clinical psychology graduate students, a master’s-level licensed psychological 
associate (LPA), social work graduate students, and one marriage and family therapy 
graduate student. Clinical psychology graduate students and the master’s-level LPA were 
supervised by two licensed clinical psychologists. Social work graduate students and the 
marriage and family therapy graduate student were supervised by licensed professionals 
in their respective fields.  
Analyses 
Multilevel modeling with fixed and random effects was used to examine symptom 
change as measured by YOQ-30 scores for individuals over the course of treatment. 
However, due to a few cases in the sample comprising a significant proportion of the 
treatment session data, only data from the first 20 treatment sessions of all cases were 
used in the model to prevent the model from being predominantly represented by a few 
cases with more data. In addition, there was a large amount of missing baseline PCM data 
in the sample. As a result, an imputed value was used to replace missing baseline PCMs 
scores. Given preliminary findings of the stability of PCM item 2 and item 3 scores over 
the course of treatment, an imputed mean value was calculated based upon all respective 
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item values for the first 20 treatment sessions for each case with missing baseline PCM 
data to comprise a baseline PCM item 2 and item 3 score. An imputed baseline item 2 
and item 3 value was calculated for 62.50% of cases in the sample, while 37.50% of the 
sample included a true baseline PCM value. 
For the multilevel modeling analyses, the stability of PCM scores over time was 
assessed using two models: one with all item 2 scores throughout treatment and another 
separate model with all item 3 scores throughout the course of treatment. Stability was 
defined as having a slope not statistically significantly different from zero. These 
repeated measures of PCM scores were modeled to provide information about the 
average change in PCM item scores over the course of treatment. The stability of YOQ-
30 scores over treatment was assessed by modeling all YOQ-30 scores over treatment, 
with stability defined as having a slope not statistically significantly different from zero. 
These repeated measures were modeled to provide information about the average change 
in psychological symptoms over the course of treatment. 
Then, a regression equation took into account each individual’s symptom level 
measured by YOQ-30 scores regressed on a variable accounting for treatment session 
number. The treatment session number variable began at zero for the initial treatment 
session and increased by one for every session. From this equation, the slope represented 
the symptom change over the course of multiple sessions, with a positive slope indicating 
an increase in psychological symptoms over treatment, a slope of zero representing no 
change in symptoms over treatment, and a negative slope indicating a decrease in 
symptoms over the course of treatment. An analysis was then conducted to model how 
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PCM item 2 and item 3 scores related to the change in psychological symptoms over 
time, i.e., affect the slope of symptom change.  
Results 
 A total of 283 PCM responses and 373 YOQ-30 responses were analyzed for 48 
participants in the sample. The average PCM item 2 response among participants in the 
sample over the course of treatment was 6.10 (SD = 2.53, 95% CI [5.81, 6.39]) with an 
average baseline response value of 6.10 (SD = 2.27, 95% CI [5.46, 6.74]). The average 
PCM item 3 response was 6.01 (SD = 2.41, 95% CI [5.74, 6.28]) with an average 
baseline response value of 6.29 (SD = 2.30, 95% CI [5.64, 6.94]). Descriptive statistics of 
PCM item 2 and item 3 over the course of treatment and at baseline for imputed and non-
imputed cases are reported in Table 1. The average baseline YOQ-30 score for students 
in the sample was 38.75 (SD = 14.10, 95% CI [34.76, 42.74]). The average final YOQ-30 
score for students in the sample was 25.21 (SD = 18.34, 95% CI [20.02, 30.40]). There 
was not a significant correlation among PCM item 2 and item 3 responses, r = 0.05, 95% 
CI [-0.07, 0.16], p = .428. 
Stability of PCM Items 
 Multilevel modeling with fixed and random effects was used to assess the stability 
of PCM item 2 and item 3 responses over the course of treatment (i.e., time; level 1) and 
between participants (level 2). For PCM item 2, a baseline model was estimated without 
any predictors (see Table 2 for fit indices). Results indicated significant differences in 
PCM item 2 responses between participants (b = 6.07, p < .001, 69.70% of the variance 
explained by level 2), indicating the need to use a random intercept to better model level 
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2 to account for level 2 variance. A random intercepts model was then estimated for PCM 
item 2 with random and fixed effects for session number (i.e., time; level 1). Session 
number as a fixed effect was not significant (b = 0.003, p = .988), indicating that session 
number was not associated with any significant change in PCM item 2 scores. However, 
with session number as a random effect, individual differences between participants 
remained significant (b = 4.16, p < .001). A model was estimated with a random slope 
estimate at level 1 for PCM item 2 to determine whether the slopes of PCM item 2 scores 
changed at different rates by different participants. However, this model would not 
converge. The number of iterations for this model was increased up to 10,000 iterations, 
but it still would not converge. Therefore, results revealed PCM item 2 responses 
significantly varied between participants but did not significantly vary when accounting 
for session number (i.e., over time; see Figure 1). Parameter estimates for all analyses in 
this section are reported in Table 3. 
 For PCM item 3, a baseline model was estimated without any predictors (see 
Table 4 for fit indices). Results indicated significant differences in PCM item 3 responses 
between participants (b = 6.16, p < .001, 72.00% of the variance explained by level 2), 
indicating the need to use a random intercept to better model level 2 and therefore 
account for level 2 variance in the model. Next, a random intercepts model was estimated 
for PCM item 3 with random and fixed effects for session number (i.e., time; level 1). 
Session number as a fixed effect was not significant (b = -0.03, p = .092), indicating that 
session number was not associated with any significant change in PCM item 3 scores. 
However, with session number as a random effect, individual differences between 
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participants remained significant (b = 4.16, p < .001; 72.00% of the variance explained 
by level 2). A model was then estimated with a random slope estimate at level 1 for PCM 
item 3 to determine whether the slopes of PCM item 3 scores changed at different rates 
by different participants. While this model was able to converge, the model was unable to 
estimate the variance around the slopes of PCM item 3 scores. Nevertheless, results 
revealed PCM item 3 responses significantly varied between participants but did not 
significantly vary by session number (i.e., over time; see Figure 2). Parameter estimates 
for all analyses in this section are reported in Table 5. 
Stability of YOQ-30 Scores 
 Multilevel modeling with fixed and random effects was used to assess the stability 
of YOQ-30 scores over the course of treatment (i.e., time; level 1) and between 
participants (level 2). A baseline model was estimated without any predictors (see Table 
6 for fit indices). Results indicated significant differences in YOQ-30 scores between 
participants (b = 29.69, p < .001, 68.60% of the variance explained by level 2), indicating 
the need to use a random intercept to better model level 2 and therefore account for level 
2 variance in the model. Next, a random intercepts model was estimated for YOQ-30 
scores with random and fixed effects for session number (i.e., time; level 1). Session 
number as a fixed effect was significant (b = -1.00, p < .001), indicating that session 
number was associated with a significant change in YOQ-30 score. With session number 
as a random effect, individual differences between participants remained significant (b = 
-1.02, p < .001), and adding in the level 1 random intercept increased the variance 
explained by level 2 to 74.60%. Finally, a model was estimated with a random slope 
PERCEIVED CRITICISM AND PSYCHOTHERAPY OUTCOME 22 
 
 
estimate at level 1 for YOQ-30 to determine whether the slopes of YOQ-30 scores 
changed at different rates by different participants. In this model, level 1 still had a 
significant residual (b = -1.02, p < .001). However, the slope was different between 
participants (p = .007). Therefore, results revealed YOQ-30 scores significantly varied 
between participants and significantly varied when accounting for session number (i.e., 
over time; see Figure 3). Parameter estimates for all analyses in this section are reported 
in Table 7. 
PCM Prediction of Treatment Response 
Multilevel modeling with fixed effects was used to examine change in YOQ-30 
scores over the course of treatment (i.e., time; level 1) and between participants (level 2) 
with PCM items 2 and 3 as predictors. Results indicated a significant effect for session 
number (b = -1.05, p < .001), indicating YOQ-30 scores decreased over treatment across 
participants. Results indicated significant variance of average YOQ-30 between 
participants (p < .001) and significant variance in the rate of YOQ-30 change between 
participants (p =.018, 72.90% of the variance explained by level 2). PCM item 2 as a 
fixed effect was not significant (b = 0.47, p = .163), indicating that PCM item 2 did not 
predict YOQ-30 score. PCM item 3 as a fixed effect was significant (b = 0.69, p = .047), 
indicating that PCM item 3 did predict YOQ-30 score. More specifically, as PCM item 3 
increased by 1, YOQ-30 increased by 0.69. When a random intercepts model was 
attempted to estimate PCM item 3 and session number as fixed and random effects, the 
model would not converge. Therefore, results revealed PCM item 3 responses 
significantly predicted YOQ-30 score over the course of treatment but the change in 
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slopes between participants could not be estimated. Parameter estimates and model fit 
indices are reported in Table 8. 
Discussion 
Stability of PCM Items 
 The results suggest that while there were between student differences regarding 
their endorsements of PC, both PCM item 2 and item 3 were relatively stable over the 
course of treatment. That is, students endorsed roughly stable levels of PC from their 
identified perceived critic over the course of treatment and reported similar levels of 
upset due to criticism from their identified perceived critic during the trial of 
psychotherapy. Neither the level of PC nor the level of upset from criticism changed 
significantly over student participation in treatment sessions. These data are consistent 
with the findings of PCM stability in the adult literature (e.g., Renshaw et al., 2003) from 
pre- to post-treatment and lend support to the temporal stability of both PCM item 2 and 
item 3 in adolescent samples. In addition, PCM scores do not significantly change when 
modeled over the course of psychotherapy sessions, which previous studies of PCM 
stability have not examined. 
 The lack of convergence for the PCM item 2 and item 3 models with a random 
slope estimate at level 1 may be accounted for due to the introduction of redundancy in 
the data with the imputed baseline item 2 and item 3 scores. For cases with missing 
baseline PCM data, the imputed baseline PCM value for item 2 and item 3 were 
calculated by taking the mean of all completed PCMs administered over the first 20 
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treatment sessions. As a result, the baseline PCM value for item 2 and item 3 reflects all 
other item 2 and item 3 values by case and therefore introduced redundancy in the model. 
 The model of YOQ-30 scores over the course of treatment revealed that there 
were between-student differences in their self-reported level of psychological symptoms. 
The findings also suggested that students’ YOQ-30 scores changed over the course of 
treatment. More specifically, students’ overall level of psychological distress decreased 
during their participation in psychotherapy. There was a modest increase in the average 
YOQ-30 scores around sessions 15 and 16, but the mean did not surpass the established 
clinical cutoff for the YOQ-30. It is also important to note that the number of students 
included in analyses tended to decrease as the session numbers reached their maximum 
for the sample. Therefore, this observed increase in YOQ-30 scores might be a reflection 
of higher symptom levels for students who were still engaged in treatment after 15 
sessions. Thus, although on average students in the sample evidenced a decrease in 
psychological distress, the decrease in mean YOQ-30 scores did not follow a consistent 
downward linear trend over treatment for those students who remained in the analyses. 
 Notably, with the observed change in YOQ-30 scores over the course of treatment 
and the observed stability in both PCM item 2 and item 3 responses over treatment, 
results indicated that PCM item responses did not change with variations in YOQ-30 
scores. The level of criticism and the level of upset endorsed by students did not change 
with decreases or increases in psychological symptoms. These results observed in an 
adolescent sample align with the findings in the adult literature that PC is relatively 
independent of self-reported psychological symptoms (Hooley & Teasdale, 1989; 
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Renshaw et al., 2003). That is, results indicated that PC remained stable over treatment 
while psychological symptoms decreased on average and thus suggest PC is relatively 
independent of psychological symptom experience and not the result of increased 
psychological symptoms resulting in an attentional bias towards or proclivity to detecting 
criticism. These results are important to consider for clinical practice as they may indicate 
a need to address criticism in the family system. The current study did not regularly 
address the criticism and instead, focused on adolescents’ attentional or cognitive 
processes through cognitive restructuring or appraisal techniques. More specifically, 
because the results from this study suggest PC does not decrease despite a decrease in 
psychological symptoms with psychotherapy, addressing aspects of criticism in the 
family environment through family therapy and communication-focused techniques, such 
as parent-child interaction therapy (PCIT), might better address levels of PC. In addition, 
because results from this study suggest the effects of PC are not adequately captured by a 
measure of psychological symptoms, it may be possible that other psychological 
assessment tools capture PC and its effects. For example, the level of distress from 
criticism measured by the PCM may also be similarly captured in the Negative Affect 
Score from the Positive and Negative Affect Schedule (PANAS; Watson, Clark, & 
Tellegan, 1988). In turn, effects of the PCM may also be reflected in other measures of 
relationship quality, such as the area of relationships with relatives assessed by the 
Quality of Life Inventory (QOLI; Frisch, Cornell, Villanueva, & Retzlaff, 1988). Future 
research should examine other psychological assessment tools that further capture the 
effects of PC.  However, these results do not necessarily indicate that PC is an irrelevant 
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treatment target and may only be addressed through family involvement in treatment. For 
example, PC may be reflective of other internal mechanisms that treatment strategies 
used in this study did not address. 
PCM Prediction of Treatment Outcome 
Analyses revealed that on average, YOQ-30 scores decreased across participants 
over the course of treatment, although average YOQ-30 scores differed between 
participants over treatment. Also, participants differed in their average rate of YOQ-30 
change. In other words, participants on average experienced reduced psychological 
symptoms over the course of treatment, but there were individual differences in 
psychological symptom severity. There were also individual differences in the rate of 
psychological symptom remittance between participants. These results are consistent with 
hypothesized findings that YOQ-30 scores would decrease on average over the course of 
psychotherapy in that participants on average experienced a reduction in psychological 
symptoms as a result of psychotherapy treatment. However, participants did not 
experience equivalent levels of psychological symptoms nor equivalent rates of symptom 
change. 
Results also suggested that PCM item 2 did not predict YOQ-30 score over 
treatment, which did not align with our second hypothesis that relatively higher PCM 
item 2 scores would be associated with relatively less symptom improvement over the 
course of psychotherapy. Contrary to findings in the adult literature that higher levels of 
PC relate to poorer treatment outcomes (Hooley & Teasdale, 1989; Masland & Hooley, 
2015; Renshaw et al., 2003), the level of PC did not significantly predict the level of 
PERCEIVED CRITICISM AND PSYCHOTHERAPY OUTCOME 27 
 
 
psychological symptoms in this sample of adolescents. Though no hypotheses were made 
regarding the relationship between PCM item 3 scores and psychological symptoms over 
the course of psychotherapy, results suggest PCM item 3 did significantly predict YOQ-
30 scores, given that higher reported distress from criticism was associated with 
relatively higher YOQ-30 scores over the course of treatment. Therefore, these findings 
may highlight a more explicit focus on emotional reactions to criticism to improve 
psychotherapy outcomes for adolescents rather than merely addressing the level or 
amount of criticism that exists in their familial relationships. Such treatment strategies 
might include building adolescents’ insight into their emotional reactions to criticism and 
incorporating emotion regulation or distress tolerance skills training so that adolescents 
may develop adaptive behaviors for managing emotional reactions to criticism to reduce 
psychological distress and improve overall functioning. 
While there were no studies located that examined how PC relates to treatment 
outcomes in adolescent samples, results from the current study suggest a different aspect 
of PC, the emotional impact or salience of criticism, is associated with higher levels of 
psychological distress over the course of adolescent treatment and not the quantity of 
criticism as hypothesized based on the adult treatment outcome literature. These findings 
mirror those of Miklowitz and colleagues (2005), who found that the level of upset from 
criticism rather than the level of criticism better predicted poorer treatment outcomes in 
adults with bipolar disorder. Miklowitz and colleagues suggested the level of upset due to 
criticism would better predict mood symptom scores and days in recovery based upon 
findings that adults with bipolar disorder are more sensitive to stress, more prone to 
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processing biases from negative stimuli, and more prone to dysfunctional attitudes. It 
might be the case that similar mechanisms are at play during adolescence. For instance, it 
is possible that some adolescents with less well-developed emotion regulation abilities 
are more readily impacted by criticism and/or highly sensitive to rejection (Silvers et al., 
2012). Based upon evidence that adolescents experience more variation in mood states 
and more extreme affect on average compared to adults (Larson, Csikszentmihalyi, & 
Graef, 1980; Larson, Moneta, Richards, & Wilson, 2002; Larson & Richards, 1994), 
distress measured in PCM item 3 may be tapping into adolescents’ emotional reactivity 
and/or emotion regulation abilities that better predict psychotherapy outcomes, which 
may account for possible differences between adolescent and adult samples. In addition, 
this emotional reactivity might be reflective of other transdiagnostic mechanisms 
associated with psychopathology, such as difficulties in regulating arousal, internalizing 
attributional bias, low distress tolerance, and fear of evaluation that may be important to 
address in psychotherapy, all of which are similar to those described by Miklowitz and 
colleagues (2005) in their sample. Given that participants’ ratings of distress about 
criticism remained stable over the course of treatment, these findings might suggest that 
the psychotherapy provided to the participants in this sample did not effectively address 
the emotional impact of criticism. In future research, it would be helpful to know whether 
targeting aspects of PC during adolescence is beneficial. It would also be useful to 
examine which transdiagnostic mechanisms may also be reflected in PC and how these 
may be addressed to improve psychotherapy outcomes. 
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An alternative explanation for observed differences in PCM item predictive 
ability between adult and adolescent samples may be that adolescents are relatively more 
sensitive to or relatively more likely to personalize criticism when compared to adults as 
a function of their age or development. For example, it has been suggested that 
adolescents more commonly perceive or even obsess that others around them are 
constantly observing and evaluating them, otherwise referred to as the “imaginary 
audience,” a construct purportedly conceptualized as developmental differences in 
cognitive perceptual biases (Vartanian, 2000). The imaginary audience experienced by 
adolescents has been theorized to result from adolescents’ evolving cognitive operational 
abilities whereby they eventually learn via interactions with others that they are not the 
central focus of others’ attention (Elkind, 1967).  From a social-cognitive perspective, as 
adolescents become better able to consider a less egocentric vantage point and possibly 
not as readily impacted (Lapsley & Murphy, 1985). In addition, the imaginary audience 
construct has been theorized to develop as a result of adolescents questioning and 
forming their own identities (O’Connor, 1995; O’Connor & Nikolic, 1990; Protinsky & 
Wilkerson, 1986). Whatever the mechanism accounting for the imaginary audience, this 
experience during the teen years might explain why distress from criticism is a better 
predictor of psychotherapy outcomes when compared to the amount of criticism 
perceived. While adolescents may be more cognitively attuned to evaluation from others 
and are actively making sense of their social relationships, a sensitivity to and 
personalization of perceived scrutiny might diminish the potential positive benefits of 
psychotherapy. Thus, PCM item 3 may be reflecting a level of self-consciousness 
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experienced by adolescents. In addition, adolescents particularly sensitive to criticism and 
reporting greater distress from criticism may perceive scrutiny and evaluation as 
particularly threatening, which may indicate that PCM item 3 is assessing a particular 
type of social anxiety. Support for this relationship between PCM item 3 and a level of 
self-consciousness or personalization of criticism was found in the current study by 
correlating PCM item 3 scores with baseline BASC-2 and BASC-3 SRP-A indices of 
Anxiety (r = 0.33, 95% CI [0.04, 0.58], p = .026), Sense of Inadequacy (r = 0.38, 95% CI 
[0.09, 0.61], p = .009), Self-Esteem (lower scores reflect less self-esteem, r = -0.38, 95% 
CI [-0.61, -0.09], p = .011), and Ego Strength (see above, r = -0.40, 95% CI [-0.63, -
0.10], p = .008). Though the magnitudes of these statistically significant correlations are 
modest, the pattern of relationships with anxiety and the associated constructs were 
consistent. Minimally, these data suggest a potentially fruitful line of future inquiry to 
understand how the emotional impact of criticism is associated with various types of 
anxiety and constructs related to self-consciousness and sensitivity to perceived scrutiny. 
In addition, future research should seek to determine how treatment might more 
effectively target the distress associated with criticism perceived by adolescents. For 
example, addressing a sensitivity to observation and evaluation from others as explained 
by the imaginary audience in psychotherapy might include social exposures designed to 
either promote acceptance of uncomfortable emotions adolescents experience related to 
evaluation from others or to promote inhibitory learning opportunities for adolescents to 
learn they are not the central focus of others’ attention and thus are not constantly being 
evaluated by others. 
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Finally, while results of the current study suggest the level of distress from 
criticism predicts adolescent treatment outcomes, the effect PC has on treatment outcome 
may differ across adolescent development. For instance, the relative importance of the 
identity of the perceived critic respondent may influence both the emotional salience of 
criticism and the relation between PC and psychotherapy outcomes across adolescent 
development and into adulthood. Because adolescents typically seek independence from 
parents during this developmental period and become more dependent on peer 
relationships (Steinberg & Silverberg, 1986), the relationship between PC and treatment 
outcome may differ. It is possible that the emotional impact of criticism and thus 
adolescents’ distress from criticism may decrease as they reach late adolescence and early 
adulthood and parents become less influential compared to peers. In addition, there is 
evidence in the literature that suggests adolescents develop more successful emotion 
regulation skills as they progress into late adolescence and early adulthood (Silvers et al., 
2012), which may suggest that PC might relate differently to psychotherapy outcome for 
older adolescents that may have more developed emotion regulation skills. More 
specifically, if older adolescents are more adaptively able to respond to PC, distress from 
criticism may be less predictive of psychotherapy outcomes. While 41.70% of the sample 
in the current study was composed of older adolescents, this study did not examine 
potential differences in the effects of PC throughout this developmental span. However, 
future research should examine how potential developmental differences from early to 
late adolescence might influence the relationship between PC and adolescent treatment 
outcome. 
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Limitations 
 The findings from this study are limited by a relatively small sample size that may 
have limited the statistical power needed for determining the ability of PCM items 2 and 
3 to predict treatment outcome based upon YOQ-30 scores. In addition, because of a 
large amount of missing PCM data at baseline (62.50% of cases, n = 30), a baseline PCM 
score was imputed for cases with missing baseline PCM data based upon an average of 
all PCM scores for that case. Though analyses revealed that both PCM items 2 and 3 
were relatively stable over the course of treatment, there were observed variations in item 
response for cases over the course of treatment. Therefore, results from this study may be 
limited due to ignoring within-person variance in PCM scores and may have inflated the 
level of bias in the sample.  
 There were also characteristics of students included in the sample that may limit 
the findings of this study. First, this study did not control for students who received 
previous psychological treatment. Students who received ASC Center services in a 
previous treatment year (16.70%, n = 8) and students who previously received therapy 
from another mental health provider other than the ASC Center (47.50%, n = 19) were 
included in analyses. Therefore, the results of this study may reflect previous treatment 
effects as opposed to effects from a single treatment year. In addition, this study only 
included participants who experienced internalizing psychopathology as measured by a 
T-score of 60 or greater on any of the internalizing scales of the BASC-2 or BASC-3 
SRP-A. As a result, no conclusions may be made about the stability of PCM ratings or 
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the relationship between PC and treatment outcomes in adolescents with externalizing 
psychopathology.  
Implications and Future Directions 
 A focus on the clinical utility of PC in predicting treatment outcomes has been 
driven by the well-established importance of EE in the treatment outcome literature 
(Hooley & Teasdale, 1989; Masland & Hooley, 2015; Renshaw, Chambless, & Steketee, 
2003) and the difficulty, unreliability, and cost of measuring EE in clinical practice 
(Masland & Hooley, 2015). Given the evidence that PC predicts treatment outcomes in 
adults it will be important to continue studying how PC may operate similarly (or not) in 
adolescent samples, where EE has also been implicated as a predictor of clinical 
outcomes. The results of this study suggest that PC is a useful target of treatment in 
adolescents and that the PCM may provide meaningful information about which teens 
might experience less optimal treatment outcomes over the course of psychotherapy. As 
such, the most important implications from this study are that for adolescents, PC as 
measured by PCM items 2 and 3 remains stable over the course of psychotherapy, even 
with decreases and increases in YOQ-30 scores, and that higher levels of upset from 
criticism measured by PCM item 3 ratings relate to higher YOQ-30 scores (i.e., more 
psychological symptoms) over the course of psychotherapy. 
Overall, these findings highlight the importance of addressing criticism in the 
family environment as one potential method for improving treatment outcomes in 
adolescents. As results suggest PC has not been implicated as a reflection of 
psychological symptom severity but rather a stable construct over psychotherapy 
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treatment, strategies aimed at affecting individual perceptions of criticism such as 
cognitive restructuring likely would not affect PCM ratings. Instead, family involvement 
in treatment would likely be warranted for adolescents who endorse high levels of upset 
from criticism to improve treatment outcomes. Indeed, results from this study suggest a 
correlation exists between PCM item 3 and the baseline BASC-2 and BASC-3 SRP-A 
index of Relations with Parents where lower scores reflect poorer relations with parents, r 
= -0.31, 95% CI [-0.56, -0.01], p = .040. Though the relationship is modest, these results 
suggest more distress from criticism is related to relatively poorer relations between 
adolescents and their parents. Strategies designed to address criticism in families may 
include a focus on effective communication or parent-directed engagement and 
psychoeducational approaches to directly address criticism, such as in the Unified 
Protocols for Transdiagnostic Treatment of Emotional Disorders in Children and 
Adolescents: Therapist Guide (Ehrenreich-May et al., 2018). 
In addition, adolescents’ emotional experiences that are reflected in PCM item 3 
might be important to address in psychotherapy. More research is needed to determine 
whether distress from criticism assessed using the PCM is a reflection of emotional 
reactivity, emotion regulation deficits, self-consciousness, social anxiety (i.e., a 
sensitivity to threat from evaluation), or the personalization of criticism and threat and 
how PC may relate to other transdiagnostic mechanisms that may be addressed in 
treatment. Attention to clinical interventions that address these constructs may be 
indicated for adolescents endorsing great distress from criticism. Such interventions 
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might include a particular type of exposure to fears of evaluation and/or emotion 
regulation and distress tolerance skills training. 
Similarly, future studies should discern potential developmental differences in the 
effects of PC from early to late adolescence. Any differences in how PC operates from 
early to late adolescence may implicate differing mechanisms at play that portend poorer 
treatment outcomes at different developmental stages. For example, it may be important 
to implement emotion regulation skills training for younger adolescents who endorse 
great distress from criticism if there is evidence to suggest distress from criticism 
assessed using the PCM predicts poorer treatment outcomes during early adolescence. In 
addition, it may be that PC functions similarly in older adolescents as in adults whereby 
the level of criticism perceived by older adolescents predicts poorer treatment outcomes 
during late adolescence and early adulthood. If such a difference is found, it may be 
important to implement interventions in the family system to reduce levels of criticism 
for older adolescents who report high levels of PC. 
Future studies should also seek to examine how PC and its underlying constructs 
may be able to predict which adolescents respond to psychotherapy and which do not. 
Though there was not enough power in the current study to examine differences in PC 
between adolescents who responded to psychotherapy and adolescents who did not (i.e., 
those who continued to experience clinical levels of psychological distress at the end of 
treatment), results from this study suggested high levels of distress from criticism were 
associated with greater psychological distress over the course of psychotherapy. Thus, the 
examination of PC’s relationship with psychotherapy outcome should be extended to 
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determine whether the PCM may provide information about adolescents who might 
continue to experience clinical psychological distress over participation in psychotherapy 
and how PC may relate to adolescents’ rate of change of psychological symptoms with 
participation in psychotherapy. 
Finally, future studies should seek to address the limitations of the current study 
by including a larger sample size to increase power and strengthen conclusions that may 
be made from results. In addition, future research should seek to collect PCM ratings at 
the first treatment meeting and consistently across treatment meetings to strengthen 
conclusions that may be made about the stability of PCM ratings. Consistently collecting 
baseline and across treatment PCM ratings may also better discern the predictive ability 
of baseline PCM ratings alone in adolescent samples. Future studies may also better 
isolate the effects of PC on adolescent psychotherapy treatment outcomes by only 
including participants in their first year of psychotherapy treatment and controlling for 
any effects of previous psychotherapy. Also, results from the current study may only be 
relevant to adolescents experiencing primarily internalizing psychopathology. The 
relationship between PC and psychotherapy outcome for adolescents with primarily 
externalizing psychopathology have not been examined to date, thus future studies should 
examine how PC operates in adolescent samples with primarily externalizing 
psychopathology. 
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Table 1  
Descriptive Statistics of PCM item 2 and PCM Item 3 Scores 
PCM Item Mean Standard 
Deviation 
95% CI 
PCM item 2 baseline 6.10 2.27 5.46, 6.74 
PCM item 2 over treatment 6.10 2.53 5.81, 6.39 
Imputed baseline PCM item 2 baseline 6.32 2.11 5.56, 7.08 
Imputed baseline PCM item 2 over treatment 6.31 2.45 5.96, 6.66 
Non-imputed baseline PCM item 2 baseline 5.73 2.63 4.40, 7.06 
Non-imputed baseline PCM item 2 over treatment 5.68 2.65 5.15, 6.21 
PCM item 3 baseline 6.29 2.30 5.64, 694 
PCM item 3 over treatment 6.01 2.41 5.74, 6.28 
Imputed baseline PCM item 3 baseline 6.32 2.16 5.56, 7.08 
Imputed baseline PCM item 3 over treatment 6.15 2.31 5.82, 6.48 
Non-imputed baseline PCM item 3 baseline 5.60 2.85 4.16, 7.04 
Non-imputed baseline PCM item 3 over treatment 5.72 2.58 5.20, 6.24 
 
Note. PCM items presented as 1 to 10 scale with higher scores reflecting more criticism 
and distress. 
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Table 2  
PCM Item 2 Model Change in -2LL and Residual Estimate 
Model Parameters -2LL -2LL 
Change 
AIC BIC Residual 
Estimate 
Residual 
Estimate 
Percent 
Change 
I 3 1094.68 n/a 1100.68 1111.613 1.81** n/a 
II 4 1094.68 0.00 1102.68 1117.26 1.81** 0.00% 
 
Note. *p < .05; **p < .001; -2LL Change and Residual Estimate Percent Change for each 
row based on the model preceding it. 
 
Model I – Fixed: intercept; Random: intercept 
Model II – Fixed: intercept, session number; Random: intercept 
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Table 3  
Parameter Estimates for PCM Item 2 Stability Model 
 Model 1 Model 2 
Parameter Parameter 
estimate 
SE 95% CI Parameter 
estimate 
SE 95% CI 
Fixed Effects   
     Intercept 6.07** 0.31 5.45, 
6.69 
6.07** 0.33 5.41, 
6.73 
     Session Number    0.0003 0.02 -0.03, 
0.03 
Random Effects   
     Intercept 4.16** 0.92 2.70, 
6.41 
4.16** 0.92 2.70, 
6.41 
Note. *p < .05; **p < .001 
 
Model I – Fixed: intercept; Random: intercept 
Model II – Fixed: intercept, session number; Random: intercept 
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Table 4  
PCM Item 3 Model Change in -2LL and Residual Estimate 
Model Parameters -2LL -2LL 
Change 
AIC BIC Residual 
Estimate 
Residual 
Estimate 
Percent 
Change 
I 3 1071.70 n/a 1077.70 1088.63 1.64** n/a 
II 4 1068.85 -2.85 1076.85 1091.44 1.62** -1.22% 
Note.*p  < .05; * *p < .001; -2LL Change and Residual Estimate Percent Change for each 
row based on the model preceding it. 
 
Model I – Fixed: intercept; Random: intercept 
Model II – Fixed: intercept, session number; Random: intercept 
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Table 5  
Parameter Estimates for PCM Item 3 Stability Model 
 Model 1 Model 2 
Parameter Parameter 
estimate 
SE 95% CI Parameter 
estimate 
SE 95% CI 
Fixed Effects   
     Intercept 6.16** 0.31 5.54, 
6.78 
6.35** 0.33 5.70, 
7.00 
     Session Number    -0.03 0.02 -0.06, 
0.01 
Random Effects   
     Intercept 4.21** 0.93 2.74, 
6.50 
4.16** 0.92 2.70, 
6.41 
Note. *p < .05; **p < .001 
 
Model I – Fixed: intercept; Random: intercept 
Model II – Fixed: intercept, session number; Random: intercept 
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Table 6  
YOQ-30 Model Change in -2LL and Residual Estimate 
Model Parameters -2LL -2LL 
Change 
AIC BIC Residual 
Estimate 
Residual 
Estimate 
Percent 
Change 
I 3 2851.92 n/a 2857.92 2869.69 85.55** n/a 
II 4 2745.11 -106.81 2753.11 2768.80 61.96** -27.57% 
III 6 2690.46 -54.65 2702.46 2725.99 45.59** -26.42% 
Note. *p < .05; **p < .001; -2LL Change and Residual Estimate Percent Change for each 
row based on the model preceding it. 
 
Model I – Fixed: intercept; Random: intercept 
Model II – Fixed: intercept, session number; Random: intercept 
Model III – Fixed: intercept, session number; Random: intercept + session number 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7  
Parameter Estimates for YOQ-30 Stability Model 
 Model 1 Model 2 Model 3 
Parameter Parameter 
estimate 
SE 95% CI Parameter 
estimate 
SE 95% CI Parameter 
estimate 
SE 95% 
CI 
Fixed Effects     
     Intercept 29.69*** 2.04 25.59, 
33.80 
36.36*** 2.09 32.18, 
40.54 
36.31*** 1.95 32.39, 
40.23 
     Session 
     Number 
   -1.00 0.09 -1.18,  
-0.83 
-1.02*** 0.17 -1.37, 
-0.68 
Random Effects    
     Intercept 186.55*** 40.87 121.43, 
286.60 
182.33*** 39.25 119.57, 
278.03 
   
     Residual       45.59*** 3.83 38.66, 
53.75 
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     Between 
        group 
        differences  
      158.06*** 37.01 99.89, 
250.12 
     Variance 
        around 
        case mean 
      0.43 2.20 -3.87, 
4.73 
     Variance 
        around 
        slope 
      0.75** 0.28 0.36, 
1.56 
Note. *p < .05; **p < .01, ***p < .001 
 
Model I – Fixed: intercept; Random: intercept 
Model II – Fixed: intercept, session number; Random: intercept 
Model III – Fixed: intercept, session number; Random: intercept + session number
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Table 8 
Parameter Estimates for PCM as a Predictor of YOQ-30 Change Model 
Parameter Parameter Estimate SE 95% CI 
Fixed Effects    
     Intercept 29.51** 3.40 22.79, 36.22 
     Session Number -1.05** 0.17 -1.40, -0.69 
     PCM Item 2 0.47 0.34 -0.19, 1.14 
     PCM Item 3 0.69* 0.35 0.01, 1.38 
Random Effects    
     Residual 49.95** 5.09 40.91, 61.00 
     Between group  
        differences 
134.39** 2.13 80.74, 223.71 
     Variance around 
        case mean 
2.02 2.13 -2.15, 6.20 
     Variance around 
        slope for time 
0.64* 0.27 0.28, 1.45 
Fit Indices -2LL 
2041.21 
AIC 
2057.21 
BIC 
2086.20 
Note. *p < .05; **p < .001 
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Figure 1. Mean PCM Item 2 Scores Over the Course of Treatment 
Figure 1. Average endorsement of PC across participants over treatment sessions. PCM 
mean item responses are scaled from ‘1’ to ‘10’ with higher item endorsement reflecting 
greater levels of PC.  
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Figure 2. Mean PCM Item 3 Scores Over the Course of Treatment 
 
Figure 2. Average endorsement of the level of upset from criticism over treatment 
sessions. PCM item 3 responses are scaled from ‘1’ to ‘10’ with higher item endorsement 
reflecting a greater level of upset as a result of criticism from the respondent’s identified 
perceived critic. 
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Figure 3. Mean YOQ-30 Scores Over the Course of Treatment 
 
Figure 3. Average psychological symptom endorsement over treatment sessions. Higher 
YOQ-30 scores reflect a higher level of psychological symptoms with decreases in YOQ-
30 scores reflecting the remittance psychological symptoms. YOQ-30 scores of 29 or 
greater represent a clinical level of psychological symptoms, and scores lower than 29 
reflect non-clinical psychological symptom experience. 
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Appendix A 
Perceived Criticism Measure 
Date __ __ / __ __ / __ __ __ __ 
 
DIRECTIONS 
For the following four questions, please circle the number on the scale that corresponds 
to your answer. 
 
 
1. How critical do you think you are of 
_____________________________________________? 
 
 
 
Not at all critical 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very critical  
 
 
2. How critical do you think _______________________________________________ is of 
you? 
 
 
 
Not at all critical 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very critical  
 
 
 
3.    When _________________________________________criticizes you, how upset do you 
get? 
 
 
 
Not at all upset 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very upset 
 
 
 
4.    When you criticize ______________________________________, how upset does he/she 
get? 
 
 
 
Not at all upset 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very upset 
 
© JM Hooley and JD Teasdale, 1989 
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Appendix B 
Perceived Criticism Measure 
Date __ __ / __ __ / __ __ __ __ 
 
DIRECTIONS 
Please identify the person that you are related to and live with who is most emotionally 
important to you. 
 _______________________________________ 
 
DIRECTIONS 
For the following four questions, please circle the number on the scale that corresponds 
to your answer. 
 
 
2. How critical do you think you are of 
_____________________________________________? 
 
 
 
Not at all critical 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very critical  
 
 
2. How critical do you think _______________________________________________ is of 
you? 
 
 
 
Not at all critical 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very critical  
 
 
 
3.    When _________________________________________criticizes you, how upset do you 
get? 
 
 
 
Not at all upset 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very upset 
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4.    When you criticize ______________________________________, how upset does he/she 
get? 
 
 
 
Not at all upset 
 
    1     2     3     4     5     6     7     8     9     10 
 
Very upset 
 
 
© JM Hooley and JD Teasdale, 1989 
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Appendix C 
To: Kurt Michael  
Psychology  
CAMPUS EMAIL  
 
From: Lisa Curtin, PhD, IRB Chairperson 
RE: Notice of IRB Approval by Expedited Review (under 45 CFR 46.110) 
Date: 11/04/2016 
RE: Notice of IRB Approval by Expedited Review (under 45 CFR 46.110) 
Agrants#: 14-0248,15-0245,13-0118 
Grant Title: Sponsors: Alleghany County Schools 
Ashe County Board of Education 
Watauga County Schools 
 
STUDY #: 17-0040 
STUDY TITLE: The Effectiveness of the Assessment, Support, and Counseling (ASC) 
Center 
Submission Type: Initial 
Expedited Category: (5) Research Involving Pre-existing Data, or Materials To Be 
Collected Solely for Nonresearch Purposes 
Renewal Date:  11/04/2016 
Expiration Date of Approval: 11/03/2017  
 
 
The Institutional Review Board (IRB) approved this study for the period indicated above. 
The IRB found that the research procedures meet the expedited category cited above. IRB 
approval is limited to the activities described in the IRB approved materials, and extends 
to the performance of the described activities in the sites identified in the IRB 
application. In accordance with this approval, IRB findings and approval conditions for 
the conduct of this research are listed below. 
 
 
All approved documents for this study, including consent forms, can be accessed by 
logging into IRBIS. Use the following directions to access approved study documents.  
1. Log into IRBIS 
2. Click "Home" on the top toolbar  
3. Click "My Studies" under the heading "All My Studies"  
4. Click on the IRB number for the study you wish to access  
5. Click on the reference ID for your submission  
6. Click "Attachments" on the left-hand side toolbar  
7. Click on the appropriate documents you wish to download 
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Approval Conditions: 
 
Appalachian State University Policies: All individuals engaged in research with human 
participants are responsible for compliance with the University policies and procedures, 
and IRB determinations. 
 
Principal Investigator Responsibilities: The PI should review the IRB's list of PI 
responsibilities. The Principal Investigator (PI), or Faculty Advisor if the PI is a student, 
is ultimately responsible for ensuring the protection of research participants; conducting 
sound ethical research that complies with federal regulations, University policy and 
procedures; and maintaining study records. 
 
Modifications and Addendums: IRB approval must be sought and obtained for any 
proposed modification or addendum (e.g., a change in procedure, personnel, study 
location, study instruments) to the IRB approved protocol, and informed consent form 
before changes may be implemented, unless changes are necessary to eliminate apparent 
immediate hazards to participants. Changes to eliminate apparent immediate hazards 
must be reported promptly to the IRB. 
 
Approval Expiration and Continuing Review: The PI is responsible for requesting 
continuing review in a timely manner and receiving continuing approval for the duration 
of the research with human participants. Lapses in approval should be avoided to protect 
the welfare of enrolled participants. If approval expires, all research activities with human 
participants must cease. 
 
Prompt Reporting of Events: Unanticipated Problems involving risks to participants or 
others; serious or continuing noncompliance with IRB requirements and determinations; 
and suspension or termination of IRB approval by an external entity, must be promptly 
reported to the IRB. 
 
Closing a study: When research procedures with human subjects are completed, please 
log into our system at https://appstate.myresearchonline.org/irb/index_auth.cfm and 
complete the Request for Closure of IRB review form. 
 
Websites: 
 
1. PI responsibilities: 
http://researchprotections.appstate.edu/sites/researchprotections.appstate.edu/files/PI%20
Responsibilities.pdf  
 
2. IRB forms: http://researchprotections.appstate.edu/human-subjects/irb-forms  
 
CC: 
Rachel Capps, Psychology 
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John Jameson, Psychology 
Jon Winek, Human Dev & Psych Counsel 
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Appendix D 
Informed Consent for Clinical Services 
We are pleased to have the opportunity to serve you and/or your child through the ASC (Assessment, Support, and 
Counseling) Center, a partnership between Ashe High School and Appalachian State University (ASU). ASC Center 
personnel are committed to providing the highest quality clinical services to students and their families, providing 
education and training for faculty and staff, and expanding the knowledge base for best practice standards through 
research.  Clinical services are provided by qualified, licensed professional providers, faculty members, and/or students 
under supervision, as appropriate.  As we proceed to work together, the following information may be helpful.   
 
Depending on your situation, our first few sessions might be spent exploring and assessing your problems and the 
possible reasons for them.  This might include written or oral testing and evaluation.  Once we understand your issues 
to the best of our ability, you and we will agree on the goals you want to accomplish.  Together, we may also agree to 
change the goals as we move along.  We may set some time frames for action.   
 
IHHS/ASC providers/faculty and students will work to ensure that the theoretical perspectives, interventions, and 
treatments used are considered the best practice methods, supported by research, and are appropriate for your needs.  
However, it is important for you to know that there are often many different approaches to similar problems.  We will 
talk with you about the pros and cons of each approach before a decision is made to go ahead with any treatment plan.  
Successful treatment or problem resolution requires a commitment from you.  There is always the possibility that our 
work will not result in the progress we hope to make.  Please let us know immediately if you have any questions or 
concerns.   
 
CONFIDENTIALITY 
 
Ordinarily, anything and everything you share with us is strictly confidential—whether you say it in person, on the 
telephone, or write it. Some of the information you give us about yourself and matters we discuss will be recorded in 
your clinical record. If we mutually decide that, in your interests, ASU/ASC Center personnel should provide some part 
of your confidential information to another professional, your insurance company, your attorney, or even you, you will 
sign a specific and time-limited release of information. You will know what is to be released, to whom, and how the 
information will be used. You will be able to stipulate the time period in which the release is to be in effect. 
 
There are some circumstances in which ASU/ASC Center providers, faculty, and/or students would be required by law 
to reveal confidential information about you without your consent. One situation would be if we learned that you were 
at imminent risk of harming yourself or another person. Another situation would be if there is reasonable suspicion of 
abuse or neglect of a child or elderly individual.  A third situation would be in the event of a court order compelling us 
to release your clinical record to a court of law. Other situations would be based on federal or state laws.  Some of these 
situations are discussed in a separate document, the Notice of Privacy Practices, which we are providing as required by 
federal law.  
 
Sound clinical practice and teaching includes consultation and discussion with other interdisciplinary providers, faculty 
members, and students, sometimes regarding specific cases.  All those affiliated with ASU/ASC Center are also legally 
bound to keep the information confidential.  If you do not object, we will not tell you about these consultations and 
discussion unless they are important to our work together. 
 
RESEARCH PARTICIPATION 
 
As indicated above, we endeavor to use best practices when providing treatment to students. In order to 
accomplish this, we regularly collect data on treatment progress, satisfaction, academic outcomes, attendance, 
and disciplinary referrals. Although we use these data to facilitate best practices, participation in this type of 
data collection in no way reduces our commitment to protecting students’ confidentiality. We also conduct 
specific research projects above and beyond these normal methods of data collection. A separate consent form is 
included in the packet and additional information is provided for parent/guardian and student consideration. 
You and your child’s participation is voluntary and refusal to participate in this research element or 
discontinuing participation will involve no penalty or loss of benefits to which you or your child are otherwise 
entitled, including services provided by the ASC Center. 
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HOW TO REACH ASC CENTER PROVIDERS, FACULTY, AND STUDENTS 
 
If it is necessary to cancel or reschedule an appointment, please do so at least 24 hours in advance.  Please cancel your 
appointment by calling 336-845-2400 (ext. 2135), between 8:30 a.m. and 3:30 p.m., Monday through Friday.  If your 
call is urgent or an emergency, please tell the operator immediately.  If you have an imminent emergency, you may also 
contact Daymark Mobile Crisis, at 336-846-HELP, call 911, or go to any hospital emergency room.  We will discuss 
other ways of dealing with crisis situations relevant to your personal situation, as needed.   
 
 
Feel free to contact Dr. Kurt Michael, Licensed Psychologist, Professor of Psychology (828-262-2272, ext. 432), or 
Whitney Van Sant, ASC Center Coordinator (336-846-2400, ext. 2135), if you have questions or comments regarding 
clinical services.   
 
I have received and been given the opportunity to read a copy of this Informed Consent for Clinical Services sheet. 
 
Signature of Student or Legally Responsible Person: 
__________________________________________________________ Date: _____________ 
  
Specify Relationship to Student and Print Name in 
Full:__________________________________________________________________________ 
 
Signature of Student: 
__________________________________________________________________________________ Date: 
_______________ 
 
Witness (optional): 
___________________________________________________________________________________  Date: 
_______________ 
___   Copy given to Student       ___ Student declined copy 
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Appendix E 
 
NOTICE OF PRIVACY PRACTICES 
 
THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND 
DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. 
PLEASE REVIEW THIS NOTICE CAREFULLY.   
 
Your health record contains personal information about you and your health.  This information about you that may 
identify you and that relates to your past, present or future physical or mental health or condition and related health care 
services is referred to as Protected Health Information (“PHI”). This Notice of Privacy Practices describes how the ASC 
Center may use and disclose your PHI in accordance with applicable law.  It also describes your rights regarding how 
you may gain access to and control your PHI.  
 
The ASC Center is required by law to maintain the privacy of PHI and to provide you with notice of our legal duties and 
privacy practices with respect to PHI. The ASC Center is required to abide by the terms of this Notice of Privacy Practices.  
We reserve the right to change the terms of this Notice of Privacy Practices at any time.  Any new Notice of Privacy 
Practices will be effective for all PHI that we maintain at that time. The ASC Center will provide you with a copy of the 
revised Notice of Privacy Practices by sending a copy to you in the mail upon request or providing one to you at your 
next appointment.  
  
HOW the ASC Center MAY USE AND DISCLOSE HEALTH INFORMATION ABOUT YOU 
 
For Treatment.  Your PHI may be used and disclosed by those who are involved in your care for the purpose of 
providing, coordinating, or managing your health care treatment and related services. This includes consultation with 
other ASC Center clinical providers, faculty, supervised students, or other treatment team members, if applicable.  We 
may disclose PHI to any other consultant only with your authorization. 
 
For Payment.  The ASC Center may use and disclose PHI so that we can receive payment for the treatment services 
provided to you.  This will only be done with your authorization. Examples of payment-related activities are: making a 
determination of eligibility or coverage for insurance benefits, processing claims with your insurance company, reviewing 
services provided to you to determine medical necessity, or undertaking utilization review activities.  If it becomes 
necessary to use collection processes due to lack of payment for services, the ASC Center will only disclose the minimum 
amount of PHI necessary for purposes of collection.   
 
For Health Care Operations.  The ASC Center may use or disclose, as needed, your PHI in order to support our 
business activities including, but not limited to, quality assurance activities, evaluation of effectiveness, licensing, 
and conducting or arranging for other business activities. For example, we may share your PHI with third parties that 
perform various business activities (e.g., billing services) provided we have a written contract with the business that 
requires it to safeguard the privacy of your PHI.   We may disclose your PHI to other ASC Center clinical providers, 
faculty, supervised students, and/or other treatment team members for training or teaching purposes.  
  
Required by Law.  Under the law, the ASC Center must make disclosures of your PHI to you upon your request.  In 
addition, we must make disclosures to the Secretary of the Department of Health and Human Services for the purpose of 
investigating or determining the ASC Center’s compliance with the requirements of the Privacy Rule. 
 
Without Authorization.  Applicable law and ethical standards permit the ASC Center to disclose information about you 
without your authorization only in a limited number of other situations.  The types of uses and disclosures that may be 
made without your authorization are those that are: 
 
 Required by Law, such as the mandatory reporting of child abuse or neglect or mandatory government agency 
audits or investigations (such as the psychology or social work licensing boards or the health department)   
 Required by Court Order  
 Necessary to prevent or lessen a serious and imminent threat to the health or safety of a person or the public.  
If information is disclosed to prevent or lessen a serious threat it will be disclosed to a person or persons 
reasonably able to prevent or lessen the threat, including the target of the threat.  
 
PERCEIVED CRITICISM AND PSYCHOTHERAPY OUTCOME 64 
 
 
Verbal Permission 
 
The ASC Center may use or disclose your information to family members who are directly involved in your treatment 
with your verbal permission. 
 
With Authorization.   Uses and disclosures not specifically permitted by applicable law will be made only with your 
written authorization, which you may revoke at any time.   
 
YOUR RIGHTS REGARDING YOUR PHI 
 
You have the following rights regarding PHI the ASC Center maintains about you.  To exercise any of these rights, please 
submit your request in writing to us at the address below or in person. 
 
 Right of Access to Inspect and Copy.  You have the right, which may be restricted only in exceptional 
circumstances, to inspect and copy PHI that may be used to make decisions about your care.  Your right to 
inspect and copy PHI will be restricted only in those situations where there is compelling evidence that access 
would cause serious harm to you.  The ASC Center may charge a reasonable, cost-based fee for copies.   
 Right to Amend.  If you feel that the PHI the ASC Center has about you is incorrect or incomplete, you may 
ask us to amend the information although we are not required to agree to the amendment.   
 Right to an Accounting of Disclosures.  You have the right to request an accounting of certain of the 
disclosures that the ASC Center makes of your PHI.  The ASC Center may charge you a reasonable fee if you 
request more than one accounting in any 12-month period. 
 Right to Request Restrictions.  You have the right to request a restriction or limitation on the use or disclosure 
of your PHI for treatment, payment, or health care operations.  We are not required to agree to your request.   
 Right to Request Confidential Communication.  You have the right to request that the ASC Center 
communicates with you about medical matters in a certain way or at a certain location. 
 Right to a Copy of this Notice.  You have the right to a copy of this notice. 
 
COMPLAINTS 
 
If you believe the ASC Center has violated your privacy rights, you have the right to file a complaint in writing to us at 
the address below or in person or with the Secretary of Health and Human Services at 200 Independence Avenue, S.W., 
Washington, D.C. 20201 or by calling (202) 619-0257.   
 
The effective date of this Notice is January 5, 2015. 
 
 
Notice of Privacy Practices 
Receipt and Acknowledgment of Notice 
 
 
Name____________________________________________________ _____________________________DOB: 
____________________________ 
        
I hereby acknowledge that I have received and have been given an opportunity to read a copy of the ASC Center Notice 
of Privacy Practices.  I understand that if I have any questions regarding the Notice or my privacy rights, I can contact 
my provider, Jennifer Wandler, or Dr. Kurt Michael at the address or phone number below or discuss them in person at 
my next appointment.   
 
Signature of Student or Legally Responsible Person*: 
____________________________________________________Date:________________ 
 
 
Specify Relationship to Student and Print Name in Full:___________________________________________________ 
            
 
PERCEIVED CRITICISM AND PSYCHOTHERAPY OUTCOME 65 
 
 
*     If you are signing as a personal representative of an individual, please describe your legal authority to act for this 
individual (power of attorney, healthcare surrogate, etc.). 
 
Additional Signature of Student or Parent, if 
needed:______________________________________________________Date:________________ 
 
Witness 
(optional):_________________________________________________________________________________Date:__
______________ 
 
 Student Refuses to Acknowledge Receipt: 
 
 
Signature of Staff 
Member:___________________________________________________________________________Date:_________
_______ 
 
 
 
 
 
The ASC Center 
Ashe County High School 
West Jefferson, NC  28694 
Whitney Van Sant: (336) 846-2400 (ext. 2135) 
Kurt Michael: (828) 262-2272 (ext. 432) 
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Appendix F 
                                      
Authorization for Use and Disclosure of Protected Health Information 
This form implements the requirements for student authorization to use and disclose health information protected by 
the federal health privacy law (45 C.F.R. parts 160, 164), the federal drug and alcohol confidentiality law (42CFR, part 
2) and state confidentiality law governing mental health, developmental disabilities, and substance abuse services (GS 
122C) 
 
Student Name: ___________________________________________________________________ Date of 
Birth: ________________ 
 
I hereby authorize: _________Daymark Recovery 
Services____________________________________________________________ 
 
To   Disclose and/or Share Protected Health Information with:  Ashe County 
Schools_______________________________________  
 
The following protected information: (Provide a specific and meaningful description of the information to be used or 
disclosed) 
Psychological evaluation results, student status, participation in services, progress made, family dynamics 
and history, safety issues, recommendations, school status, school concerns, grades, testing, behavioral 
concerns, school progress, treatment plan, clinical impressions, substance use/abuse issues, treatment, and 
history. 
 
The Purpose of Disclosure:  
Coordination of services, participation in the Daymark School-Based Therapy and ASC Center Programs, 
treatment planning, and Daymark Mobile Crisis Services. 
______________________________________________________________________________________
______________________ 
 
_______________________________________________REDISCLOSURE_______________________
______________________ 
 
Once information is disclosed pursuant to this signed authorization, I understand that the federal health privacy law (45 
C.F.R. Part 164) protecting health information may not apply to the recipient of the information and, therefore, may not 
prohibit the recipient from redisclosing it.  Other laws, however, may prohibit redisclosure.  When this agency 
discloses mental health and developmental disabilities information protected by state law (G.S. 122C) or substance 
abuse treatment information protected by federal law (42 C.F.R. Part 2), it must inform the recipient of the information 
that redisclosure is prohibited except as permitted or required by these two laws.  ASU Institute for Health and Human 
Services Notice of Privacy Practices describes the circumstances when disclosure is permitted or required by these 
laws. 
 
________________________________________EXPIRATION AND 
REVOCATION____________________________________ 
 
I understand that, with certain exceptions, I have the right to revoke this authorization at any time.  [If I want to revoke 
this authorization, I must do so in writing.]  If not revoked earlier, this authorization expires automatically upon 
____________________________ or one year from the date it is signed, whichever is earlier.   
_______________________________________________NOTICE OF 
VOLUNTARINESS____________________________________________ 
 
I understand that I may refuse to sign this authorization form.   A readable photocopy or fax of this authorization shall 
have the same force and effect as this original. 
 
PERCEIVED CRITICISM AND PSYCHOTHERAPY OUTCOME 67 
 
 
_____________________________________________________SIGNATURES_____________________________
________________________ 
  
Signature of Legally Responsible Person: ___________________________________________________________ 
Date: ______________   
Specify Relationship to Student and Print Name in 
Full:____________________________________________________________________ 
 
Signature of Student: ___________________________________________________________________________ 
Date: _______________ 
 
Additional Parent/Guardian Signature: _____________________________________________________________ 
Date: _______________ 
 
Witness (optional): _____________________________________________________________________________ 
Date: _______________ 
 
___   Copy given to Parent/guardian/student       ___  Parent/guardian/student declined copy 
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Appendix G 
                                      
Authorization for Use and Disclosure of Protected Health Information 
This form implements the requirements for student authorization to use and disclose health information protected by 
the federal health privacy law (45 C.F.R. parts 160, 164), the federal drug and alcohol confidentiality law (42CFR, part 
2) and state confidentiality law governing mental health, developmental disabilities, and substance abuse services (GS 
122C) 
 
Student Name: _________________________________________ Date of Birth: ________________ 
 
I hereby authorize: ASC Center/Appalachian State University Licensed Professional Providers, Faculty 
Members, and/or Supervised Students   
 
To   Disclose and/or Share Protected Health Information with:   
 
_________Ashe County 
Schools______________________________________________________________________ 
 
The following protected information: (Provide a specific and meaningful description of the information to be used or 
disclosed) 
Psychological evaluation results, student status, participation in services, progress made, family dynamics 
and history, safety issues, recommendations, school status, school concerns, grades, testing, behavioral 
concerns, school progress, treatment plan, clinical impressions, substance use/abuse issues, treatment, and 
history. 
______________________________________________________________________________________
______________________ 
 
The Purpose of Disclosure:  
Coordination of services, participation in the School-Based Therapy and ASC Center Programs, and 
treatment planning. 
______________________________________________________________________________________
______________________ 
 
_______________________________________________REDISCLOSURE_______________________
______________________ 
 
Once information is disclosed pursuant to this signed authorization, I understand that the federal health privacy law (45 
C.F.R. Part 164) protecting health information may not apply to the recipient of the information and, therefore, may not 
prohibit the recipient from redisclosing it.  Other laws, however, may prohibit redisclosure.  When this agency 
discloses mental health and developmental disabilities information protected by state law (G.S. 122C) or substance 
abuse treatment information protected by federal law (42 C.F.R. Part 2), it must inform the recipient of the information 
that redisclosure is prohibited except as permitted or required by these two laws.  ASU Institute for Health and Human 
Services Notice of Privacy Practices describes the circumstances when disclosure is permitted or required by these 
laws. 
 
________________________________________EXPIRATION AND 
REVOCATION____________________________________ 
 
I understand that, with certain exceptions, I have the right to revoke this authorization at any time.  [If I want to revoke 
this authorization, I must do so in writing.]  If not revoked earlier, this authorization expires automatically upon 
____________________________ or one year from the date it is signed, whichever is earlier.   
_______________________________________________NOTICE OF 
VOLUNTARINESS____________________________________________ 
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I understand that I may refuse to sign this authorization form.   A readable photocopy or fax of this authorization shall 
have the same force and effect as this original. 
 
_____________________________________________________SIGNATURES_____________________________
________________________ 
  
Signature of Legally Responsible Person: ___________________________________________________________ 
Date: ______________   
Specify Relationship to Student and Print Name in 
Full:____________________________________________________________________ 
 
Signature of Student: ___________________________________________________________________________ 
Date: _______________ 
 
Additional Parent/Guardian Signature: _____________________________________________________________ 
Date: _______________ 
 
Witness (optional): _____________________________________________________________________________ 
Date: _______________ 
 
___   Copy given to Parent/guardian/student       ___  Parent/guardian/student declined copy 
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Appendix H 
                                      
Authorization for Use and Disclosure of Protected Health Information 
This form implements the requirements for student authorization to use and disclose health information protected by 
the federal health privacy law (45 C.F.R. parts 160, 164), the federal drug and alcohol confidentiality law (42CFR, part 
2) and state confidentiality law governing mental health, developmental disabilities, and substance abuse services (GS 
122C) 
 
Student Name: _________________________________________ Date of Birth: ________________ 
 
I hereby authorize: ASC Center/Appalachian State University Licensed Professional Providers, Faculty 
Members, and/or Supervised Students   
 
To   Disclose and/or Share Protected Health Information with:   
 
_________DAYMARK Recovery 
Services______________________________________________________________________ 
 
The following protected information: (Provide a specific and meaningful description of the information to be used or 
disclosed) 
Psychological evaluation results, student status, participation in services, progress made, family dynamics 
and history, safety issues, recommendations, school status, school concerns, grades, testing, behavioral 
concerns, school progress, treatment plan, clinical impressions, substance use/abuse issues, treatment, and 
history. 
______________________________________________________________________________________
______________________ 
 
The Purpose of Disclosure:  
Coordination of services, participation in the Daymark School-Based Therapy and ASC Center Programs, 
treatment planning, and Daymark Mobile Crisis Services. 
______________________________________________________________________________________
______________________ 
 
_______________________________________________REDISCLOSURE_______________________
______________________ 
 
Once information is disclosed pursuant to this signed authorization, I understand that the federal health privacy law (45 
C.F.R. Part 164) protecting health information may not apply to the recipient of the information and, therefore, may not 
prohibit the recipient from redisclosing it.  Other laws, however, may prohibit redisclosure.  When this agency 
discloses mental health and developmental disabilities information protected by state law (G.S. 122C) or substance 
abuse treatment information protected by federal law (42 C.F.R. Part 2), it must inform the recipient of the information 
that redisclosure is prohibited except as permitted or required by these two laws.  ASU Institute for Health and Human 
Services Notice of Privacy Practices describes the circumstances when disclosure is permitted or required by these 
laws. 
 
________________________________________EXPIRATION AND 
REVOCATION____________________________________ 
 
I understand that, with certain exceptions, I have the right to revoke this authorization at any time.  [If I want to revoke 
this authorization, I must do so in writing.]  If not revoked earlier, this authorization expires automatically upon 
____________________________ or one year from the date it is signed, whichever is earlier.   
_______________________________________________NOTICE OF 
VOLUNTARINESS____________________________________________ 
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I understand that I may refuse to sign this authorization form.   A readable photocopy or fax of this authorization shall 
have the same force and effect as this original. 
 
_____________________________________________________SIGNATURES_____________________________
________________________ 
  
Signature of Legally Responsible Person: ___________________________________________________________ 
Date: ______________   
Specify Relationship to Student and Print Name in 
Full:____________________________________________________________________ 
 
Signature of Student: ___________________________________________________________________________ 
Date: _______________ 
 
Additional Parent/Guardian Signature: _____________________________________________________________ 
Date: _______________ 
 
Witness (optional): _____________________________________________________________________________ 
Date: _______________ 
 
___   Copy given to Parent/guardian/student       ___  Parent/guardian/student declined copy 
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Appendix I 
Ashe County Schools/Appalachian State University 
Informed Consent for Participation in Research 
 
Title of Project:  The Effectiveness of the Assessment, Support, and Counseling (ASC) 
Center 
Investigator(s):  Dr. Kurt Michael, Dr. John Paul Jameson  
 
I. Purpose of Research: 
As described on the Consent to Treatment form that was signed and on-file at the ASC Center, we are 
committed to providing your children with effective interventions to address their behavioral and academic 
concerns. As you are already aware, we regularly collect data on treatment progress, satisfaction, academic 
outcomes, attendance, and disciplinary referrals that help us serve your children better. We now request 
your permission to present anonymous data regarding the effects of ASC Center services in the form of 
presentations and publications to an audience of professionals outside of the ASC Center. Information 
about the effects of the ASC Center services will be presented anonymously so that your children’s 
identities will not be disclosed.  
 
II. Procedures: 
In addition to the information collected regularly as part of ASC Center involvement, students and 
parents will be asked to complete a few brief assessments before, during, and after ASC Center 
services have been delivered. The assigned ASC Center clinician will review these documents in 
detail with the students and parents (before and after) and if there is evidence on the assessments of 
significant distress or discomfort, interventions will be delivered (or referrals made) immediately, up 
to and including the disclosure of this information to parents/guardians should it deemed consistent 
with the “limits of confidentiality” described on the original Consent to Treatment Form (that is, 
danger to self or others, reasonable suspicion of abuse).  
 
III. Risks: 
As described above, the risks of participation in this project do not exceed the normal 
risks associated with receiving mental health/behavioral treatment in other settings. We 
will abide by all standards of confidentiality and we are committed to the safe and 
effective treatment of your children’s concerns. 
 
IV. Benefits: 
Your participation in this project will help other professionals and society at large learn more about 
providing effective mental health and behavioral treatment for high school students.   
 
V. Extent of Anonymity and Confidentiality: 
The answers you and your student provide on the assessments will be kept confidential 
and under lock and key. Only authorized ASC Center personnel will know the identity of 
your children. When the data is presented, it will not include your children’s identity. The 
information will be presented anonymously.   
 
VI. Compensation: 
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There will not compensation for your participation. ASC Center services are provided at 
no cost to you or your child.   
 
VII. Freedom to Withdraw: 
You or your child do not have to answer any questions if you do not want to and you can stop at any 
time. 
 
VIII. Approval of Research: 
This research project has been approved, as required, by the Institutional Review Board 
of Appalachian State University.  
 
IRB Approval Date: 11/04/2016   Approval Expiration Date: 
11/03/2017 
 
IX. Participant's Responsibilities:  
I voluntarily agree to participate in this study. I have the following responsibilities:  
 
1. Review this consent form 
2. Complete the assessments honestly if I consent to participation 
 
X. Participant’s Permission:   
I have read and understand the Informed Consent and conditions of this project. I have 
had all my questions answered. I hereby acknowledge the above and give my voluntary 
consent by completing and signing this form.  
 
Signature of Student or Legally Responsible Person: _______________________________________ Date: 
_____________ 
  
Specify Relationship to Student and Print Name in 
Full:_______________________________________________________ 
 
Signature of Student: __________________________________________________________ Date: _______________ 
 
 
Should I have any questions about this research or its conduct, I may contact:  
Kurt Michael, michaelkd@appstate.edu, (828) 262-2272, extension 432 
IRB Administrator, Research and Sponsored Programs, Appalachian State University, 
Boone, NC 28608, (828) 262-2692, irb@appstate.edu.
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